Articles tagged with Rheumatology
Researchers found that normal-appearing lupus skin contains the same inflammatory signals as skin with rashes, suggesting a primed state for inflammation. The study's findings provide new insights into how UV light triggers rashes in lupus patients and highlight the potential for precision medicine in treating the disease.
The UK National Osteoporosis Guideline Group has published a new guideline for the prevention and treatment of osteoporosis, which includes updated recommendations for vertebral fracture detection and anabolic treatment options. The guidance aims to improve service provision in both primary and secondary care settings.
A recent study suggests that many older adults with rheumatoid arthritis are not prescribed disease-modifying medications, despite guidelines calling for early and aggressive treatment. Only 45% of patients over 65 were prescribed these medications, highlighting the need to improve prescribing practices among primary care physicians.
Dr Nicholas Fuggle, a UK researcher, has been awarded the prestigious ESCEO-IOF Pierre Meunier Young Scientist Award for his significant contributions to research in musculoskeletal ageing. He is recognized for his work on determinants of musculoskeletal ageing and digital healthcare.
Professor René Rizzoli has been recognized for his significant and longstanding contribution to the advancement of osteoporosis research through his work on bone metabolism and mineralization. He is a respected researcher, clinician, and leader in the field of osteoporosis, with a strong focus on prevention and treatment.
The Virtual WCO-IOF-ESCEO 2022 Congress will feature leading experts on osteoporosis, osteoarthritis, and musculoskeletal diseases, with a focus on new clinical research and advances in prevention and patient care. Prestigious awards will also be presented.
The International Osteoporosis Foundation awarded Professor Thierry Thomas the IOF Committee of Scientific Advisors (CSA) Medal of Achievement for his outstanding scientific contributions to osteoporosis. The award recognizes his work on secondary fracture prevention and post-fracture care coordination programs.
Professor Elaine Dennison has been awarded the IOF Olof Johnell Science Award for her significant work in musculoskeletal aging, osteoporosis, and metabolic bone diseases. She is recognized as an internationally renowned clinician, researcher, and educator.
Researchers identified common features of pediatric antiphospholipid syndrome, a rare autoimmune disease causing inflammation and recurring blood clots. Nearly half of children with APS experienced recurrent blood clots despite treatment, highlighting the need for early diagnosis and prevention.
The European Alliance of Associations for Rheumatology (EULAR) has published guidelines for analyzing safety and effectiveness of new therapies using observational data. The guidelines aim to increase trustworthiness of results gained from observational data.
A biodegradable nanoparticle has shown promise in reducing skin and lung scarring in mice with scleroderma. The treatment targets specific immune cells responsible for the disease's chronic inflammation and scarring.
A study suggests that targeting necroptosis in muscle fibers using an inhibitor can lessen myositis-induced muscle weakness and cell death, promoting muscle regeneration. This approach shows promise for treating polymyositis with potentially fewer infectious complications than current immunosuppressive therapies.
Researchers found higher-than-expected levels of antiphospholipid autoantibodies in COVID-19 patients, causing endothelial cell activation and promoting clotting. Removing these antibodies from blood samples lost the activation effect, suggesting a potential cause of severe COVID-19 symptoms.
Researchers aim to determine if knee structure changes predict clinical outcomes in people with osteoarthritis. The study will examine 76,000 X-rays and clinical data from diverse cohorts to establish healthy knee structure ranges.
Patients under immunosuppressive therapy have increased risk of severe COVID-19 disease courses if they don't respond to primary vaccination. A recent study found that a third booster vaccination is safe and effective in these patients, who were initially unable to produce antibodies after vaccination.
Researchers developed a new 'Easy-BILAG' tool to measure lupus disease progression, enabling accurate and consistent assessments in 91.3% of cases. The single-page document uses color-coding to make assessment more user-friendly, reducing completion time from 80 minutes to under an hour.
A registry study found that people with inflammatory RMDs, such as rheumatoid arthritis and psoriatic arthritis, tolerate their COVID vaccine well, with short-lived reactions being the most common side effect. The majority of participants were able to continue on their normal medication with no changes.
Researchers found that defibrotide suppresses neutrophil release of NETs and reduces downstream blood-clotting in mice with antiphospholipid syndrome. The treatment neutralizes toxic histones, preventing activation of blood vessel cells.
A study published in Science Translational Medicine reveals that blocking the excess production of MIF could lead to disease remission and prevent disability and mortality linked to SpA. Researchers have successfully tested a MIF blocker, called MIF098, in pre-clinical models.
Researchers will focus on understanding the disease, identifying B cell characteristics and plasma cells that create attacking antibodies. The study aims to enhance knowledge of SLE pathogenesis and differences in clinical manifestations, outcomes, and therapeutic responses.
The Lupus Research Alliance is funding two projects that examine why lupus varies for each person. Researchers will investigate the differences in genetic and environmental factors contributing to lupus variability.
The new EULAR consensus provides guidance for investigating treatments in people at risk of RA. The guidelines recommend considering subclinical inflammation, clinical arthritis, or progression to RA as study endpoints across trials.
A new study examines the similarities and differences among disease activity indices used to monitor rheumatoid arthritis. Researchers found that while there are high correlations among the indices, they were not interchangeable, highlighting the need for further analysis of RA in patients using various indices.
The FDA has granted orphan drug status to Octagam 10%, the first and only IVIg treatment for adult dermatomyositis. The therapy is expected to become the first treatment option for adults with this rare disease, which affects approximately 10 out of every million U.S. residents.
Researchers at Washington University School of Medicine found that COVID-19 vaccination elicited a response in nearly nine out of ten people with weakened immune systems. However, the responses were only about one-third as strong as those mounted by healthy people. Despite this, the discovery is encouraging news for a population at hig...
A study published in Current Rheumatology Reviews found that rehabilitation exercises significantly improved functional strength and reduced weight in knee osteoarthritis patients. The researchers also noted an increase in exercise adherence among the rehabilitation group compared to the control group.
A new study found that parental smoking may increase the risk of developing rheumatoid arthritis in children when they reach adulthood. The research, published in Arthritis & Rheumatology, associated parental smoking with a 75% higher risk of developing the disease, even after controlling for personal smoking habits as an adult.
Researchers discovered a protein called CTRP9 associated with pulmonary function in scleroderma patients with interstitial lung disease. Patients with higher CTRP9 levels developed more severe lung disease, while low levels were linked to preserved function. The study suggests CTRP9 could help predict treatment needs for these patients.
A mobile application developed by Universitat Autonoma de Barcelona and UPC researchers has been tested for its ability to predict the severity of disabling fatigue in patients with chronic fatigue syndrome/myalgic encephalomyelitis, particularly in women. The app measures heart rate variability and shares results with medical staff.
The European Alliance of Associations for Rheumatology taskforce provides guidelines for treating severe COVID-19 with immunomodulatory therapies. The recommendations consider the individual's condition and stage of the disease, including antiviral medicines, oxygen therapy, and anticoagulation.
The European Alliance of Associations for Rheumatology (EULAR) has established a framework to address the unmet need for support of female rheumatologists and other healthcare professionals in academic rheumatology. The framework outlines six thematic areas with 29 potential interventions to accelerate gender-equitable career advancement.
A global review of diagnosis delays in axial spondyloarthritis reveals common challenges, including inadequate patient access to rheumatologists and poorly defined referral pathways. The report aims to empower stakeholders to reduce this delay and improve patient outcomes.
Children with juvenile idiopathic arthritis (JIA) are at high risk for uveitis relapses after discontinuing disease-modifying antirheumatic drugs (DMARDs). The study found that patients are more likely to experience uveitis events within the first 3-24 months after DMARD withdrawal.
Maxime Dougados and Josef Smolen are the recipients of the EULAR Meritorious Service Award, which honors their contributions to the field of rheumatology. They have published over 1000 articles and have promoted initiatives such as FOREUM and ACR/EULAR criteria for rheumatoid arthritis.
Researchers found that online mental health intervention improved anxiety and depression in people with scleroderma, a disease causing skin and connective tissue tightening. The four-week program offered group mental health intervention from trained peer support leaders, resulting in significant improvements six weeks later.
A new study published in Arthritis & Rheumatology found that only a minority of patients with knee osteoarthritis used non-surgical care such as physical therapy and knee injections. The study suggests that surgery may be more commonly substituted for conservative care in regions with high rates of knee replacements.
Researchers discovered a possible link between oral microbes and rheumatoid arthritis, finding similar bacterial compositions in patients' mouths as those at risk of developing the disease. The study suggests that potentially pro-inflammatory bacteria, such as Prevotella and Veillonella, may play a role in the disease
A new protocol called Quit Connect has been shown to increase electronic referrals to free, state-run tobacco quitlines among patients with rheumatic diseases. The program, which leverages electronic health record prompts for nurses and medical assistants, resulted in a 71% increase in referrals.
A recent study estimates that 858,000 Americans use opioids for knee pain, resulting in $0.5 billion annual costs and nearly $14 billion lifetime costs. The study suggests substantial savings from preventing opioid use for knee osteoarthritis pain management.
Radiological images confirm that COVID-19 can trigger autoimmune reactions leading to rheumatoid arthritis flares and other musculoskeletal disorders. Imaging helps explain prolonged symptoms and directs patients to the right physician for treatment.
The study reveals a significant disparity in lupus prevalence across racial and ethnic groups, with female rates significantly higher than male rates. The analysis estimates that approximately 204,295 individuals in the US have been diagnosed with lupus as of 2018.
A new study found that lower hydroxychloroquine blood levels are associated with a higher risk of clots in lupus patients. By monitoring blood levels, clinicians may be able to reduce clotting rates by up to 12% with increased dosing.
Researchers are developing new classification criteria for antiphospholipid syndrome (APS), a life-threatening autoimmune disorder, to improve its diagnosis and treatment. The new criteria will help identify patients most likely to have APS, allowing for high-quality research and better prevention and treatment options.
A new study analyzed medical claims data from Taiwan, finding that patients with rheumatoid arthritis live longer after disease-modifying antirheumatic drugs called biologics became available in 2003. The estimated lifetime cost was $72,953, highlighting the need for cost-effectiveness evaluation.
David T. Felson, a renowned Boston University rheumatologist, has been honored with the Lee C. Howley Prize from the Arthritis Foundation for his groundbreaking research on osteoarthritis (OA). His work has led to significant advances in understanding OA risk factors, treatments, and outcome measurement.
Researchers from HSS presented studies on renal disorders, venous thromboembolism after total knee replacement, and pediatric patients with rheumatologic diseases. The surveys also explored perceptions of COVID-19 risk among rheumatologists and the use of clinical disease activity indexes in telemedicine.
The American College of Rheumatology (ACR) honored 37 distinguished members with the 2020 Master of the ACR designation for their contributions to rheumatology research and patient care. The ACR also recognized leading researchers and clinicians with its Awards of Distinction, including the Presidential Gold Medal and the Paulding Phel...
The new RA guideline recommends starting patients on methotrexate and continuing with treatment, rather than rapidly switching to other drugs. The guideline also aims to minimize the use of glucocorticoids due to their serious side effects.
Research highlights the need for tuberculosis (TB) screening and ongoing clinical care for people on methotrexate living in areas with high TB prevalence. Methotrexate users taking corticosteroids or immunosuppressants are at increased risk of TB infection.
A new study shows that methotrexate significantly improves physical function and reduces inflammation in adults with primary knee osteoarthritis. Patients who received methotrexate treatment had improvements in WOMAC scores and reduced inflammatory markers, while those taking glucosamine showed no significant benefits.
The new guideline recommends increased use of biologic drugs, reduced steroid treatment, and regular immunizations for infectious diseases. Disease-modifying treatments are now more rapidly escalated in JIA patients, reducing the need for oral or intravenous steroids.
A new study found that people of color with rheumatic disease are more likely to experience poor health outcomes from COVID-19 infection, including hospitalization and necessary ventilation support. Black and Latinx patients had significantly higher odds of needing hospitalization and ventilation support compared to white patients.
Researchers analyzed data from the Global Burden of Disease Study 2017 to find a high burden of musculoskeletal disorders across the globe. The team found approximately 1.3 billion prevalent cases and 121,300 deaths due to these conditions.
Studies found Black, Latinx, and Asian patients with rheumatic diseases are more likely to experience severe COVID-19 outcomes. These disparities will worsen existing health issues for patients with rheumatic disease during the pandemic
A study of 141 pediatric patients transferred to an adult rheumatology clinic found that continued insurance coverage and referral from a pediatric rheumatologist reduced delays in attending adult visits. Pediatric patients with connective tissue diseases or Black race were particularly vulnerable to unscheduled hospitalizations.
A recent study published in The Lancet Rheumatology found that nearly 90% of shoulder replacement implants last more than ten years. Patients reported continued benefits from the operation, with a sustained positive effect on their lives for at least a decade.
Dr Basil Masri was awarded the IOF Medal of Achievement in 2020 for his significant contributions to understanding and managing osteoporosis. He has also made notable achievements in developing registries and tools, such as the Jordanian Hip Fracture registry and FRAX tool.
The prevalence of gout increased worldwide between 1990 and 2017, reaching approximately 41.2 million cases in 2017. High body mass index and impaired kidney function were identified as key risk factors for the disease.
A major global systematic review has identified several jobs that may increase the risk of knee osteoarthritis, including agriculture, construction, and service work. The study found that workers in these industries are more likely to develop knee OA due to increased physical stress and repetitive activities.
The study analyzed 600 COVID-19 cases in patients with rheumatic diseases and found no association between immunosuppressant intake and hospitalization. Treatment with high doses of prednisone was associated with a higher risk of hospitalization, while TNF-alpha inhibitors showed reduced hospitalization rates.